scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1047182994 |
P356 | DOI | 10.1007/S00401-010-0698-6 |
P932 | PMC publication ID | 2887939 |
P698 | PubMed publication ID | 20490813 |
P5875 | ResearchGate publication ID | 44619136 |
P50 | author | Hazel Urwin | Q114407900 |
Astrid Authier | Q114407901 | ||
FReJA Consortium | Q114407902 | ||
John Collinge | Q21165693 | ||
Christine Van Broeckhoven | Q2247235 | ||
John Q. Trojanowski | Q6253636 | ||
William Seeley | Q8018255 | ||
Elizabeth M. C. Fisher | Q21259007 | ||
Rosa Rademakers | Q28777946 | ||
Stuart Pickering-Brown | Q30003369 | ||
Janice Holton | Q30089851 | ||
Dennis W. Dickson | Q30504740 | ||
Myron F. Weiner | Q37370228 | ||
Jillian J. Kril | Q37840325 | ||
Samir Kumar-Singh | Q38329822 | ||
Julie van der Zee | Q40284433 | ||
Jonathan D Rohrer | Q42407224 | ||
John Van Swieten | Q42684069 | ||
Peter Johannsen | Q44553907 | ||
Glenda Halliday | Q45304807 | ||
David G. Munoz | Q46312748 | ||
Han-Xiang Deng | Q55692589 | ||
Sebastiaan Engelborghs | Q56616406 | ||
Bruce L. Miller | Q56825815 | ||
Ronald C. Petersen | Q56839853 | ||
Martin Rossor | Q56850440 | ||
Eileen H Bigio | Q57020324 | ||
Vivianna M Van Deerlin | Q59820064 | ||
Peter Paul De Deyn | Q60327954 | ||
Charles L White | Q60638965 | ||
Manuela Neumann | Q66730291 | ||
Adrian M Isaacs | Q88683796 | ||
Keith A Josephs | Q90859127 | ||
Neill R Graff-Radford | Q91360658 | ||
Kimmo Hatanpaa | Q91409013 | ||
Simon Mead | Q91709870 | ||
Harro Seelaar | Q92438245 | ||
P2093 | author name string | Tamas Revesz | |
Ian R Mackenzie | |||
Joseph E Parisi | |||
Jeremy M Brown | |||
David M Mann | |||
Gary Adamson | |||
Ida E Holm | |||
Felix Geser | |||
Shabnam Ghazi-Noori | |||
Jorgen E Nielsen | |||
Valerie Doodeman | |||
P2860 | cites work | Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia | Q24309521 |
Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease | Q24628685 | ||
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype | Q24642852 | ||
A new subtype of frontotemporal lobar degeneration with FUS pathology | Q24647697 | ||
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis | Q28236796 | ||
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 | Q28236805 | ||
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
FUS pathology in basophilic inclusion body disease | Q28261473 | ||
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein | Q29619232 | ||
Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. | Q33364603 | ||
Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration | Q33830991 | ||
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease | Q33955976 | ||
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration | Q33999208 | ||
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update | Q34020227 | ||
The role of tau (MAPT) in frontotemporal dementia and related tauopathies | Q34348115 | ||
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies | Q35607253 | ||
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease | Q35927831 | ||
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions | Q35928153 | ||
alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases | Q36452247 | ||
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series | Q36960858 | ||
TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study | Q37082139 | ||
Loss of progranulin function in frontotemporal lobar degeneration | Q37105126 | ||
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. | Q37171556 | ||
The role of CHMP2B in frontotemporal dementia | Q37368297 | ||
Rethinking ALS: the FUS about TDP-43. | Q37419912 | ||
The heritability and genetics of frontotemporal lobar degeneration. | Q37425094 | ||
Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation | Q38411857 | ||
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro | Q40063451 | ||
Inheritance of frontotemporal dementia | Q41679025 | ||
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations | Q41942745 | ||
Neurofilament inclusion body disease: a new proteinopathy? | Q42444985 | ||
An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusions | Q42503598 | ||
TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations | Q42509587 | ||
Distribution of basal ganglia lesions in generalized variant of Pick's disease: a clinicopathological study of four autopsy cases. | Q42512593 | ||
Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His | Q42631618 | ||
Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions | Q46686145 | ||
Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study | Q46850360 | ||
Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study | Q48247819 | ||
Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene | Q48428808 | ||
FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. | Q48433435 | ||
Valosin-containing protein gene mutations: clinical and neuropathologic features | Q48491139 | ||
Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family | Q48558596 | ||
Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative study | Q48620412 | ||
Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. | Q50414784 | ||
Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 family | Q50547594 | ||
Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group. | Q53342375 | ||
Distribution of cerebral cortical lesions in Pick's disease with Pick bodies: a clinicopathological study of six autopsy cases showing unusual clinical presentations. | Q53350043 | ||
Frontotemporal dementia | Q56388056 | ||
Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions | Q57306354 | ||
Frequency oftau mutations in three series of non-Alzheimer's degenerative dementia | Q57306412 | ||
Dementia lacking distinctive histology (DLDH) revisited | Q59549734 | ||
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry | Q59881380 | ||
A Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3 | Q60597019 | ||
Frontotemporal dementia | Q79355717 | ||
TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD | Q81415911 | ||
P433 | issue | 1 | |
P921 | main subject | frontotemporal lobar degeneration | Q18579 |
P304 | page(s) | 33-41 | |
P577 | publication date | 2010-05-20 | |
P1433 | published in | Acta Neuropathologica | Q343168 |
P1476 | title | FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration | |
P478 | volume | 120 |